Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.

Slides:



Advertisements
Similar presentations
Cardiovascular Risk Assessment
Advertisements

Assessment of Overweight and Obesity and the Need for Weight Loss Dr. David L. Gee FCSN/PE 446 Nutrition, Weight Control & Exercise.
Plant stanol ester in the treatment and prevention guidelines 0.
CVD risk estimation and prevention: An overview of SIGN 97.
OBESITY and CHD Nathan Wong. OBESITY AHA and NIH have recognized obesity as a major modifiable risk factor for CHD Obesity is a risk factor for development.
Lipid Disorders and Management in Diabetes
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Canadian Diabetes Association Clinical Practice Guidelines Dyslipidemia Chapter 24 G. B. John Mancini, Robert A. Hegele, Lawrence A. Leiter.
Cholesterol and Lipids TIPS Wokefield Park 15/5/2013.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
Lipids 101 Cardiology Board Review Med-Peds Style!
Final Exam Tuesday, 6/5, 2 PM Closed book – Essay and MC/TF Determining Energy Needs – p – Indirect calorimetry – Be able to do the calculations.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
CHOLESTEROL LOWERING.
Diagnosis and Treatment of Dyslipidemia  New guidelines are based on the “Adult Treatment Plan III (ATP III)” 2004  Focus = multiple risk factor assessment.
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Understanding blood lipids and glucose How a Healthy Lifestyle can improve your numbers Susan Fullmer, PhD RD Associate Teaching Professor Nutrition, Dietetics,
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
TM © 1999 Professional Postgraduate Services ® S: Total Mortality Reduction in a Subgroup of Patients With Diabetes Proportion.
DYSLIPIDEMIA IN ADULTS WITH DIABETES* 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada *Updated in Leiter.
Diabetes Trials Unit University of Oxford WebSite: Lipids in Diabetes Study.
The Science of Plant Stanol Ester. Contents Background Plant stanol ester and LDL-cholesterol lowering Dose-response of plant stanol ester with high daily.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
MI: Risk Factors and Primary Prevention. Risk Factors Factors that appear to increase the general population’s chances of experiencing a health problem.
Downloaded from Slide 1 Ezetimibe Coadministered with Atorvastatin in Patients with Hypercholesterolemia and Coronary Heart.
Role of Rosuvastatin in the Treatment of Dyslipidemia
Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.
Global impact of ischemic heart disease World Heart Federation, 2011.
LDL-C target levels (mg/dL)  2 RF:
Check the Lipid Profile? Why? Douglas W. Teske, MD The Heart Center Nationwide Children’s Hospital Douglas W. Teske, MD The Heart Center Nationwide Children’s.
Department of Family & Community Medicine
Nutrition and Cardiovascular Disease. Cardiovascular Disease Includes heart attack, stroke Includes heart attack, stroke Leading cause of death in the.
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Medical Management of obesity Perinatal ANGELS Conference Feb 17, 2005 Philip A. Kern.
Slide 1 EZT 2002-W-6022-SS Ezetimibe Co-administered with Statins: Efficacy and Tolerability Copyright © 2003 MSP Singapore Company, LLC. All rights reserved.
Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.
Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP
Cholesterol. What is cholesterol? Waxy, fat-like substance found in all cells. Dietary cholesterol – found only in animal-based foods Blood cholesterol.
Haffner SM, Alexander CM, Cook TJ, Boccuzzi SJ, Musliner TA, Pedersen TR, Kjekshus J, Pyorala K for the 4S Group Reduced Coronary Events in Simvastatin-Treated.
Group work 5 Hypertension case discussions. Objectives At the end of this session, the trainees should: Be able to explain steps of correct BP measurement.
AA-2-1 Jerome D. Cohen, MD, FACC, FACP Professor of Internal Medicine / Cardiology Director, Preventive Cardiology Programs St. Louis University Health.
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
 2010 Cengage-Wadsworth Preventing Cardiovascular Disease Chapter 11.
Copyright® Raisio Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced.
CVD Epidemiology Case Studies Nathan D. Wong PhD, FACC, Associate Professor and Director, Heart Disease Prevention Program, University of California, Irvine.
NS 210: Seminar 8 Nutritional Assessment in Disease Prevention.
An aortic aneurysm can rupture (dissecting aneurysm) and cause massive blood loss, circulatory shock and rapid death.
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults Scott W. Rypkema, M.D.
Case 2: Dyslipidaemia in Type 2 Diabetes Mellitus.
Cholesterol Measurement All adults should have their blood cholesterol measured every 5 years May be in non-fasting state Fasting preferred
Lipid profiles in Cardio Vascular Diseases. What is a lipid profile? The lipid profile is a group of tests that are often ordered together to determine.
Cholesterol-lowering effects of a stanol- ester containing low-fat margarine used in conjunction with a strict lipid-lowering diet Andersson A et al. Eur.
NS 210: Seminar 8 Nutritional Assessment in Disease Prevention Leslie Young MS RD LDN.
HEARTS & MINDS Lowering Cholesterol with Plant Stanol Ester Opening Remarks Herbert Schuster, M.D., Ph.D. Humboldt University Berlin, Berlin, Germany.
Cholesterol-Lowering Ability of a Phytostanol Softgel Supplement in Adults with Mild to Moderate Hypercholesterolemia Woodgate D et al. Lipids. 2006;41:
Plant stanol esters in low-fat yogurt reduces total and low-density lipoprotein cholesterol and low-density lipoprotein oxidation in normocholesterolemic.
National Cholesterol Education Program
Classification of total cholesterol levels
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Case 1: A 73-year-old white female with carotid disease
1 Physical Activity, Health, and Chronic Disease chapter 1 chapter
Goals & Guidelines A summary of international guidelines for CHD
Case 1: A 78-year-old white female with hypertension and hyperlipidemia Discussion Points: In that this patient has documented atherosclerotic vascular.
Section 6: Update on lipid treatment guidelines
Presentation transcript:

Case 1: Elevated LDL-C in a Young Adult

Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except for hypercholesterolaemia when fasting, the patient was in excellent health  Fasting analysis (lipid profile):  TC: 280 mg/dl(7.2 mmol/l)  HDL-C: 60 mg/dl(1.6 mmol/l)  TG: 140 mg/dl(1.6 mmol/l)  Calculated LDL-C: 192 mg/dl(4.9 mmol/l)  Lp(a): 13 mg/dl  Repeated blood sampling confirmed the lipid profile Case 1: Elevated LDL-C in a Young Adult

Page 3 of 10 *DALY; disability-adjusted life years Other parameters:  Thyroid, renal and hepatic values: normal  Blood pressure: 110/70 mmHg  There were no clinical signs of atherosclerosis Case 1: Elevated LDL-C in a Young Adult

Page 4 of 10 *DALY; disability-adjusted life years Family history:  negative for hypertension, diabetes mellitus and premature CVD  the patient said that his parents and older brother had normal lipid values The patient:  never smoked  was not overweight: 173 cm and 64 kg, or 5 ft 8 in and 140 lb, BMI 21.4 kg/m 2  vigorously played tennis on weekends in addition to jogging 5-6 km (3-4 miles) 2-3 times a week Case 1: Elevated LDL-C in a Young Adult

Page 5 of 10 *DALY; disability-adjusted life years Dietary recommendations:  The patient was advised to follow the general cholesterol-lowering diet (NCEP Step I Diet), including:  total fat not exceeding 30% of energy intake  saturated fat not exceeding 10% of energy intake  not more than 300 mg/day dietary cholesterol  Lipid values were checked over a period of several months, and LDL-C stabilised at about 170 mg/dl (4.4 mmol/l) Case 1: Elevated LDL-C in a Young Adult

Page 6 of 10 *DALY; disability-adjusted life years What do you recommend to the patient? Begin statin therapy Begin low-dose cholestyramine (8 g/day) in a divided dose Begin ezetimibe 10 mg/day Begin fibrate therapy Adding plant sterols in functional foods to diet Continue with the current programme Case 1: Elevated LDL-C in a Young Adult ABCDEFABCDEF

Page 7 of 10 *DALY; disability-adjusted life years Answer: E. Recommend adding plant sterols to functional foods in the diet LDL-C remained elevated (>160 mg/dl, or >4.1 mmol/l) despite exercise and maximum efforts towards dietary control. However, given the patient’s relative youth, otherwise acceptable lipid profile, including high HDL-C and the absence of other risk for CHD, it would be best to defer lipid-lowering pharmacotherapy, which is usually a lifelong therapy. The patient’s LDL-C:HDL-C ratio (2.8) is now at a desirable level (<3) for primary prevention. Still, it would be best to reduce his LDL-C to <130 mg/dl (<3.4 mmol/l). Case 1: Elevated LDL-C in a Young Adult

Page 8 of 10 *DALY; disability-adjusted life years Phytosterol characteristics:  Phytosterol-containing foods are a dietary supplement which lowers the mean LDL-C levels by 10-15% in addition to any other treatment previously followed Case 1: Elevated LDL-C in a Young Adult

Page 9 of 10 *DALY; disability-adjusted life years Study results from patients similar to this case Effective LDL lowering Case 1: Elevated LDL-C in a Young Adult Placebo 1.8 g Sitostanol2.6 g Sitostanol Figure 1 (Miettinen T et al. N Engl J Med. 1995;333: ). Long-term LDL lowering could be shown.

Page 10 of 10 *DALY; disability-adjusted life years Evidence:  Phytosterol therapy is in line with the updated NCEP ATPIII guidelines. The patient’s absolute 10-year CHD risk according to Framingham is below 5%, placing the patient in the low-risk group. The recommended LDL-C treatment goal in this risk category is <160 mg/dl (4.1 mmol/l), and the threshold level for considering drug therapy is ≥190 mg/dl (≥5.0 mmol/l).  Two large studies on asymptomatic persons at risk of coronary heart disease (WOSCOPS, AFCAPS/TexCAPS) have shown that lifestyle changes and lowering LDL-C can substantially reduce the risk of a heart attack (myocardial infarction) in patients with moderately elevated LDL-C. Case 1: Elevated LDL-C in a Young Adult